Background: Growth failure in infants born with CHD is a persistent problem, even in those provided with adequate nutrition.
Objective: To summarise the published data describing the change in urinary metabolites during metabolic maturation in infants with CHD and identify pathways amenable to therapeutic intervention.
Design: Scoping review.